Detalhe da pesquisa
1.
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet
; 399(10338): 1886-1901, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569466
2.
Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system.
Breast Cancer Res Treat
; 191(3): 665-675, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988767
3.
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Lancet
; 393(10166): 40-50, 2019 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449625
4.
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Int J Radiat Oncol Biol Phys
; 118(1): 107-114, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598723
5.
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
J Clin Oncol
; : JCO2302445, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759121
6.
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 770-778, 2023 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592721
7.
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415.
Int J Radiat Oncol Biol Phys
; 116(1): 39-49, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736921
8.
Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic.
Perm J
; 26(2): 54-63, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933666
9.
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.
JCO Clin Cancer Inform
; 6: e2100188, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776901
10.
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
J Clin Oncol
; 39(21): 2367-2374, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739848
11.
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415.
PLoS One
; 16(4): e0249123, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852571
12.
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
Am J Clin Oncol
; 43(3): 173-179, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985516
13.
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 5(5): 664-670, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30763425
14.
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Radiother Oncol
; 135: 19-24, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015166
15.
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 102(2): 287-295, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29913254
16.
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
J Clin Oncol
; 34(20): 2325-32, 2016 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044935